Pharmafile Logo

Webinar: Demand assessment – Reflecting real world choices

October 9, 2015 | Demand assessment, methodology 

How study design which reflects doctors’ real world choices can optimise results.

There is no “one size fits all” approach to conducting demand assessments.

The best studies utilise a methodology which is appropriate to the product in development, the market in which it will launch, and which gives the respondent the most realistic experience. 

In this webinar quantitative experts Duncan Munro and Will Tolley demonstrate, utilising knowledge and experience garnered from Research Partnership’s 18 years of conducting global quantitative research studies for pharma, how study design which reflects doctors’ real world choices can optimise results. 

Effective methodology
We discuss how to select the most appropriate approach in order to ensure an effective demand assessment methodology is achieved

Framing the question
We examine how best to frame a question in order to gain maximum insight and to make the task more realistic for respondents

Case study examples
Using real life case study examples, we demonstrate a number of key challenges and explore the ways in which researchers can overcome these issues in order to better reflect real world choices

Answer your demand assessment questions

To view the webinar please visit: 
http://www.researchpartnership.com/news/2015/09/webinar-demand-assessment-reflecting-real-world-choices/

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Free Thinking: Behavioural economics

Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?

Article: The Colombia Conundrum

Published in eye for pharma 30 January by Marc Yates

Ageing in China: The Implications for Healthcare

Published in eye for pharma 12 December by Marc Yates

Exploring MINT: Part 4 – Turkey

In the fourth and final of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in...

Getting to grips with Russia’s healthcare market

As a non-Russian, trying to understand the complexities of the multiple overlapping levels of Russia’s healthcare system can be baffling at times. Information is often inaccessible or data simply doesn't...

Exploring MINT: Part 3 – Nigeria

In the third of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Nigeria.

Exploring MINT: Part 2 – Indonesia

In the second of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Indonesia, with...

Free Thinking: Leveraging the ASEAN Market

If you can only research one ASEAN market, which one do you choose?Our Free Thinking paper investigates the opportunities for pharma in ASEAN and outlines the factors you need to...

Free Thinking: Biosimilars: Friend or foe to healthcare?

Our Free Thinking white paper looks at the opportunities for biosimilars and the threats to innovator biologics.